Despite the numerous technological advancements in various fields including health, finding a platform to merge data and technology with the view of fighting cancer has proven to be a significant challenge. It is this challenge that entrepreneur Eric Lefkofsky has taken on by cofounding Tempus. Tempus is dedicated to using technology and structured data on cancer patients and their treatments to develop precision medicine for cancer treatment.
Through its platform made up of analytics software, Tempus aims at streamlining the copious clinical data on cancer patients by digitizing the data. This will be used to develop a structured cancer patient database. Through gene sequencing, the company hopes to create a genomic database for cancer patients that it can then use to develop precision medicine for treating cancer and better cancer management practices. This new development marks a significant milestone for the University of Michigan Law School-trained lawyer who has a strong passion for helping cancer patients and their loved ones and more information click here.
Career and Education Background
Eric Lefkofsky attended the University of Michigan – Ann Arbor where he graduated with an undergraduate degree in 1991. After graduating top of his class, he rejoined the university’s Law School in 1991 for his Juris Doctor degree. However, after graduating in 1994 he did not opt for law practice; he instead embarked on an entrepreneurial journey that unrivalled success. He started his entrepreneurial journey in 2001 when he founded InnerWorkings. Three years later, he added to the branding company with the founding of a logistics company, Echo Logistics. In 2006, Mr. Lefkofsky tried his hand in the financial investment sector with the founding of MediaBank and Lightbank five years later. He also cofounded the hugely successful Groupon in 2007 and Uptake in 2014 and learn more about Eric.
In addition to actively engaging in the management of these companies, Mr. Lefkofsky also serves on board of Lurie’s Children’s Memorial Hospital and Art Institute, all based in Chicago. He also serves on the board of Steppenwolf Theatre Company where he is the chairman of the trustees’ board. University of Chicago’s Booth School of Business hired him as an adjunct professor. He previously served as a lecturer at various universities’ business and management schools.